ProfileGDS4132 / 223809_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 24% 19% 29% 23% 26% 20% 28% 23% 32% 29% 31% 30% 33% 36% 34% 24% 37% 24% 31% 27% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 10155.365724
GSM201543Muscle PCOS pioglitazone 12134.683519
GSM201544Muscle PCOS pioglitazone 16174.616329
GSM201545Muscle PCOS pioglitazone 20160.028523
GSM201829Muscle PCOS pioglitazone 23165.525726
GSM201830Muscle PCOS pioglitazon 25145.520720
GSM201831Muscle PCOS pioglitazone 27163.794728
GSM201832Muscle PCOS pioglitazone 3153.352323
GSM201833Muscle PCOS pioglitazone 4176.443832
GSM201834Muscle PCOS pioglitazone 8168.218229
GSM201835Muscle PCOS after pioglitazone 10262.873431
GSM201836Muscle PCOS after pioglitazone 12263.898130
GSM201837Muscle PCOS after pioglitazone 16267.284733
GSM201838Muscle PCOS after pioglitazone 20280.76236
GSM201839Muscle PCOS after pioglitazone 23278.051634
GSM201840Muscle PCOS after pioglitazone 25252.799824
GSM201841Muscle PCOS after pioglitazone 27279.366737
GSM201842Muscle PCOS after pioglitazone 3242.860324
GSM201843Muscle PCOS after pioglitazone 4274.5731
GSM201844Muscle PCOS after pioglitazone 8260.921327